0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Oncology (Anti-cancer Drugs) - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-19J7533
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
China Oncology Anti cancer Drugs Market Report Forecast 2021 2027
BUY CHAPTERS

Oncology (Anti-cancer Drugs) - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-19J7533
Report
November 2023
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oncology (Anti-cancer Drugs) - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Oncology (Anti-cancer Drugs) -  Market

Oncology (Anti-cancer Drugs) - Market

The global Oncology (Anti-cancer Drugs) market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Oncology (Anti-cancer Drugs) in various end use industries. The expanding demands from the Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy) and Hormonal Therapy, are propelling Oncology (Anti-cancer Drugs) market. Blood Cancer, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Breast Cancer segment is estimated at % CAGR for the next seven-year period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oncology (Anti-cancer Drugs), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Oncology (Anti-cancer Drugs) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oncology (Anti-cancer Drugs) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oncology (Anti-cancer Drugs) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oncology (Anti-cancer Drugs) covered in this report include Roche, Novartis, Celgene, Amgen, Johnson & Johnson, GlaxoSmithKline, Eli lilly & Co, Pfizer and Merck & Co., etc.
The global Oncology (Anti-cancer Drugs) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Novartis
Celgene
Amgen
Johnson & Johnson
GlaxoSmithKline
Eli lilly & Co
Pfizer
Merck & Co.
Sanofi

Scope of Oncology (Anti-cancer Drugs) - Market Report

Report Metric Details
Report Name Oncology (Anti-cancer Drugs) - Market
CAGR 5%
Global Oncology (Anti-cancer Drugs) market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oncology (Anti-cancer Drugs) market, Segment by Type:
  • Blood Cancer
  • Breast Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Others
Global Oncology (Anti-cancer Drugs) market, by Application
  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy
  • Others
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Oncology (Anti-cancer Drugs) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Oncology (Anti-cancer Drugs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the Oncology (Anti-cancer Drugs) - Market report?

Ans: The Applications covered in the Oncology (Anti-cancer Drugs) - Market report are Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy, Others

What are the Type segmentation covered in the Oncology (Anti-cancer Drugs) - Market report?

Ans: The Types covered in the Oncology (Anti-cancer Drugs) - Market report are Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Others

1 Oncology (Anti-cancer Drugs) Market Overview
1.1 Oncology (Anti-cancer Drugs) Product Overview
1.2 Oncology (Anti-cancer Drugs) Market Segment by Type
1.2.1 Blood Cancer
1.2.2 Breast Cancer
1.2.3 Gastrointestinal Cancer
1.2.4 Prostate Cancer
1.2.5 Others
1.3 Global Oncology (Anti-cancer Drugs) Market Size by Type
1.3.1 Global Oncology (Anti-cancer Drugs) Market Size Overview by Type (2018-2029)
1.3.2 Global Oncology (Anti-cancer Drugs) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Oncology (Anti-cancer Drugs) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oncology (Anti-cancer Drugs) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Oncology (Anti-cancer Drugs) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Oncology (Anti-cancer Drugs) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Oncology (Anti-cancer Drugs) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Oncology (Anti-cancer Drugs) Sales Breakdown by Type (2018-2023)
2 Global Oncology (Anti-cancer Drugs) Market Competition by Company
2.1 Global Top Players by Oncology (Anti-cancer Drugs) Sales (2018-2023)
2.2 Global Top Players by Oncology (Anti-cancer Drugs) Revenue (2018-2023)
2.3 Global Top Players by Oncology (Anti-cancer Drugs) Price (2018-2023)
2.4 Global Top Manufacturers Oncology (Anti-cancer Drugs) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oncology (Anti-cancer Drugs) Market Competitive Situation and Trends
2.5.1 Oncology (Anti-cancer Drugs) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Oncology (Anti-cancer Drugs) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology (Anti-cancer Drugs) as of 2022)
2.7 Date of Key Manufacturers Enter into Oncology (Anti-cancer Drugs) Market
2.8 Key Manufacturers Oncology (Anti-cancer Drugs) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oncology (Anti-cancer Drugs) Status and Outlook by Region
3.1 Global Oncology (Anti-cancer Drugs) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oncology (Anti-cancer Drugs) Historic Market Size by Region
3.2.1 Global Oncology (Anti-cancer Drugs) Sales in Volume by Region (2018-2023)
3.2.2 Global Oncology (Anti-cancer Drugs) Sales in Value by Region (2018-2023)
3.2.3 Global Oncology (Anti-cancer Drugs) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Oncology (Anti-cancer Drugs) Forecasted Market Size by Region
3.3.1 Global Oncology (Anti-cancer Drugs) Sales in Volume by Region (2024-2029)
3.3.2 Global Oncology (Anti-cancer Drugs) Sales in Value by Region (2024-2029)
3.3.3 Global Oncology (Anti-cancer Drugs) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oncology (Anti-cancer Drugs) by Application
4.1 Oncology (Anti-cancer Drugs) Market Segment by Application
4.1.1 Chemotherapy
4.1.2 Targeted Therapy
4.1.3 Immunotherapy (Biologic Therapy)
4.1.4 Hormonal Therapy
4.1.5 Others
4.2 Global Oncology (Anti-cancer Drugs) Market Size by Application
4.2.1 Global Oncology (Anti-cancer Drugs) Market Size Overview by Application (2018-2029)
4.2.2 Global Oncology (Anti-cancer Drugs) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Oncology (Anti-cancer Drugs) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oncology (Anti-cancer Drugs) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Oncology (Anti-cancer Drugs) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Oncology (Anti-cancer Drugs) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Oncology (Anti-cancer Drugs) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Oncology (Anti-cancer Drugs) Sales Breakdown by Application (2018-2023)
5 North America Oncology (Anti-cancer Drugs) by Country
5.1 North America Oncology (Anti-cancer Drugs) Historic Market Size by Country
5.1.1 North America Oncology (Anti-cancer Drugs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oncology (Anti-cancer Drugs) Sales in Volume by Country (2018-2023)
5.1.3 North America Oncology (Anti-cancer Drugs) Sales in Value by Country (2018-2023)
5.2 North America Oncology (Anti-cancer Drugs) Forecasted Market Size by Country
5.2.1 North America Oncology (Anti-cancer Drugs) Sales in Volume by Country (2024-2029)
5.2.2 North America Oncology (Anti-cancer Drugs) Sales in Value by Country (2024-2029)
6 Europe Oncology (Anti-cancer Drugs) by Country
6.1 Europe Oncology (Anti-cancer Drugs) Historic Market Size by Country
6.1.1 Europe Oncology (Anti-cancer Drugs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oncology (Anti-cancer Drugs) Sales in Volume by Country (2018-2023)
6.1.3 Europe Oncology (Anti-cancer Drugs) Sales in Value by Country (2018-2023)
6.2 Europe Oncology (Anti-cancer Drugs) Forecasted Market Size by Country
6.2.1 Europe Oncology (Anti-cancer Drugs) Sales in Volume by Country (2024-2029)
6.2.2 Europe Oncology (Anti-cancer Drugs) Sales in Value by Country (2024-2029)
7 Asia-Pacific Oncology (Anti-cancer Drugs) by Region
7.1 Asia-Pacific Oncology (Anti-cancer Drugs) Historic Market Size by Region
7.1.1 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oncology (Anti-cancer Drugs) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Oncology (Anti-cancer Drugs) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Oncology (Anti-cancer Drugs) Forecasted Market Size by Region
7.2.1 Asia-Pacific Oncology (Anti-cancer Drugs) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oncology (Anti-cancer Drugs) Sales in Value by Region (2024-2029)
8 Latin America Oncology (Anti-cancer Drugs) by Country
8.1 Latin America Oncology (Anti-cancer Drugs) Historic Market Size by Country
8.1.1 Latin America Oncology (Anti-cancer Drugs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oncology (Anti-cancer Drugs) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Oncology (Anti-cancer Drugs) Sales in Value by Country (2018-2023)
8.2 Latin America Oncology (Anti-cancer Drugs) Forecasted Market Size by Country
8.2.1 Latin America Oncology (Anti-cancer Drugs) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oncology (Anti-cancer Drugs) Sales in Value by Country (2024-2029)
9 Middle East and Africa Oncology (Anti-cancer Drugs) by Country
9.1 Middle East and Africa Oncology (Anti-cancer Drugs) Historic Market Size by Country
9.1.1 Middle East and Africa Oncology (Anti-cancer Drugs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oncology (Anti-cancer Drugs) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Oncology (Anti-cancer Drugs) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Oncology (Anti-cancer Drugs) Forecasted Market Size by Country
9.2.1 Middle East and Africa Oncology (Anti-cancer Drugs) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oncology (Anti-cancer Drugs) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Roche Oncology (Anti-cancer Drugs) Products Offered
10.1.5 Roche Recent Development
10.2 Novartis
10.2.1 Novartis Company Information
10.2.2 Novartis Introduction and Business Overview
10.2.3 Novartis Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novartis Oncology (Anti-cancer Drugs) Products Offered
10.2.5 Novartis Recent Development
10.3 Celgene
10.3.1 Celgene Company Information
10.3.2 Celgene Introduction and Business Overview
10.3.3 Celgene Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Celgene Oncology (Anti-cancer Drugs) Products Offered
10.3.5 Celgene Recent Development
10.4 Amgen
10.4.1 Amgen Company Information
10.4.2 Amgen Introduction and Business Overview
10.4.3 Amgen Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Amgen Oncology (Anti-cancer Drugs) Products Offered
10.4.5 Amgen Recent Development
10.5 Johnson & Johnson
10.5.1 Johnson & Johnson Company Information
10.5.2 Johnson & Johnson Introduction and Business Overview
10.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Johnson & Johnson Oncology (Anti-cancer Drugs) Products Offered
10.5.5 Johnson & Johnson Recent Development
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Company Information
10.6.2 GlaxoSmithKline Introduction and Business Overview
10.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 GlaxoSmithKline Oncology (Anti-cancer Drugs) Products Offered
10.6.5 GlaxoSmithKline Recent Development
10.7 Eli lilly & Co
10.7.1 Eli lilly & Co Company Information
10.7.2 Eli lilly & Co Introduction and Business Overview
10.7.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Eli lilly & Co Oncology (Anti-cancer Drugs) Products Offered
10.7.5 Eli lilly & Co Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Information
10.8.2 Pfizer Introduction and Business Overview
10.8.3 Pfizer Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pfizer Oncology (Anti-cancer Drugs) Products Offered
10.8.5 Pfizer Recent Development
10.9 Merck & Co.
10.9.1 Merck & Co. Company Information
10.9.2 Merck & Co. Introduction and Business Overview
10.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Merck & Co. Oncology (Anti-cancer Drugs) Products Offered
10.9.5 Merck & Co. Recent Development
10.10 Sanofi
10.10.1 Sanofi Company Information
10.10.2 Sanofi Introduction and Business Overview
10.10.3 Sanofi Oncology (Anti-cancer Drugs) Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Sanofi Oncology (Anti-cancer Drugs) Products Offered
10.10.5 Sanofi Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oncology (Anti-cancer Drugs) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oncology (Anti-cancer Drugs) Industrial Chain Analysis
11.4 Oncology (Anti-cancer Drugs) Market Dynamics
11.4.1 Oncology (Anti-cancer Drugs) Industry Trends
11.4.2 Oncology (Anti-cancer Drugs) Market Drivers
11.4.3 Oncology (Anti-cancer Drugs) Market Challenges
11.4.4 Oncology (Anti-cancer Drugs) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oncology (Anti-cancer Drugs) Distributors
12.3 Oncology (Anti-cancer Drugs) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
    Table 1. Major Company of Blood Cancer
    Table 2. Major Company of Breast Cancer
    Table 3. Major Company of Gastrointestinal Cancer
    Table 4. Major Company of Prostate Cancer
    Table 5. Major Company of Others
    Table 6. Global Oncology (Anti-cancer Drugs) Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. Global Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (K MT)
    Table 8. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type (2018-2023)
    Table 9. Global Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (US& Million)
    Table 10. Global Oncology (Anti-cancer Drugs) Market Share in Value by Type (2018-2023)
    Table 11. Global Oncology (Anti-cancer Drugs) Price by Type (2018-2023) & (USD/MT)
    Table 12. Global Oncology (Anti-cancer Drugs) Sales by Type (2024-2029) & (K MT)
    Table 13. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type (2024-2029)
    Table 14. Global Oncology (Anti-cancer Drugs) Sales by Type (2024-2029) & (US$ Million)
    Table 15. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type (2024-2029)
    Table 16. Global Oncology (Anti-cancer Drugs) Price by Type (2024-2029) & (USD/MT)
    Table 17. North America Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (K MT)
    Table 18. North America Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (US$ Million)
    Table 19. Europe Oncology (Anti-cancer Drugs) Sales (K MT) by Type (2018-2023)
    Table 20. Europe Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (US$ Million)
    Table 21. Asia-Pacific Oncology (Anti-cancer Drugs) Sales (K MT) by Type (2018-2023)
    Table 22. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (US$ Million)
    Table 23. Latin America Oncology (Anti-cancer Drugs) Sales (K MT) by Type (2018-2023)
    Table 24. Latin America Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (US$ Million)
    Table 25. Middle East and Africa Oncology (Anti-cancer Drugs) Sales (K MT) by Type (2018-2023)
    Table 26. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (US$ Million)
    Table 27. Global Oncology (Anti-cancer Drugs) Sales by Company (2018-2023) & (K MT)
    Table 28. Global Oncology (Anti-cancer Drugs) Sales Share by Company (2018-2023)
    Table 29. Global Oncology (Anti-cancer Drugs) Revenue by Company (2018-2023) & (US$ Million)
    Table 30. Global Oncology (Anti-cancer Drugs) Revenue Share by Company (2018-2023)
    Table 31. Global Market Oncology (Anti-cancer Drugs) Price by Company (2018-2023) & (USD/MT)
    Table 32. Global Oncology (Anti-cancer Drugs) Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 33. Global Oncology (Anti-cancer Drugs) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology (Anti-cancer Drugs) as of 2022)
    Table 35. Date of Key Manufacturers Enter into Oncology (Anti-cancer Drugs) Market
    Table 36. Key Manufacturers Oncology (Anti-cancer Drugs) Product Type
    Table 37. Mergers & Acquisitions, Expansion Plans
    Table 38. Global Oncology (Anti-cancer Drugs) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Global Oncology (Anti-cancer Drugs) Sales by Region (2018-2023) & (K MT)
    Table 40. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Region (2018-2023)
    Table 41. Global Oncology (Anti-cancer Drugs) Sales by Region (2018-2023) & (US$ Million)
    Table 42. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Region (2018-2023)
    Table 43. Global Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
    Table 44. Global Oncology (Anti-cancer Drugs) Sales by Region (2024-2029) & (K MT)
    Table 45. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Region (2024-2029)
    Table 46. Global Oncology (Anti-cancer Drugs) Sales by Region (2024-2029) & (US$ Million)
    Table 47. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Region (2024-2029)
    Table 48. Global Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
    Table 49. Global Oncology (Anti-cancer Drugs) Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 50. Global Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (K MT)
    Table 51. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application (2018-2023)
    Table 52. Global Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (US$ Million)
    Table 53. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application (2018-2023)
    Table 54. Global Oncology (Anti-cancer Drugs) Price by Application (2018-2023) & (USD/MT)
    Table 55. Global Oncology (Anti-cancer Drugs) Sales by Application (2024-2029) & (K MT)
    Table 56. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application (2024-2029)
    Table 57. Global Oncology (Anti-cancer Drugs) Sales by Application (2024-2029) & (US$ Million)
    Table 58. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application (2024-2029)
    Table 59. Global Oncology (Anti-cancer Drugs) Price by Application (2024-2029) & (USD/MT)
    Table 60. North America Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) (K MT)
    Table 61. North America Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (US$ Million)
    Table 62. Europe Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) (K MT)
    Table 63. Europe Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (US$ Million)
    Table 64. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) (K MT)
    Table 65. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (US$ Million)
    Table 66. Latin America Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) (K MT)
    Table 67. Latin America Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (US$ Million)
    Table 68. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) (K MT)
    Table 69. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (US$ Million)
    Table 70. North America Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (K MT)
    Table 71. North America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2018-2023)
    Table 72. North America Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (US$ Million)
    Table 73. North America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2018-2023)
    Table 74. North America Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (K MT)
    Table 75. North America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2024-2029)
    Table 76. North America Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (US$ Million)
    Table 77. North America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2024-2029)
    Table 78. Europe Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (K MT)
    Table 79. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2018-2023)
    Table 80. Europe Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (US$ Million)
    Table 81. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2018-2023)
    Table 82. Europe Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (K MT)
    Table 83. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2024-2029)
    Table 84. Europe Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (US$ Million)
    Table 85. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2024-2029)
    Table 86. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Region (2018-2023) & (K MT)
    Table 87. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Region (2018-2023)
    Table 88. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Region (2018-2023) & (US$ Million)
    Table 89. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Value by Region (2018-2023)
    Table 90. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Region (2024-2029) & (K MT)
    Table 91. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Region (2024-2029)
    Table 92. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Region (2024-2029) & (US$ Million)
    Table 93. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Value by Region (2024-2029)
    Table 94. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (K MT)
    Table 95. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2018-2023)
    Table 96. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (US$ Million)
    Table 97. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2018-2023)
    Table 98. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (K MT)
    Table 99. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2024-2029)
    Table 100. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (US$ Million)
    Table 101. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2024-2029)
    Table 102. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (K MT)
    Table 103. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2018-2023)
    Table 104. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (US$ Million)
    Table 105. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2018-2023)
    Table 106. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (K MT)
    Table 107. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2024-2029)
    Table 108. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (US$ Million)
    Table 109. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2024-2029)
    Table 110. Roche Company Information
    Table 111. Roche Introduction and Business Overview
    Table 112. Roche Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 113. Roche Oncology (Anti-cancer Drugs) Product
    Table 114. Roche Recent Development
    Table 115. Novartis Company Information
    Table 116. Novartis Introduction and Business Overview
    Table 117. Novartis Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 118. Novartis Oncology (Anti-cancer Drugs) Product
    Table 119. Novartis Recent Development
    Table 120. Celgene Company Information
    Table 121. Celgene Introduction and Business Overview
    Table 122. Celgene Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 123. Celgene Oncology (Anti-cancer Drugs) Product
    Table 124. Celgene Recent Development
    Table 125. Amgen Company Information
    Table 126. Amgen Introduction and Business Overview
    Table 127. Amgen Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 128. Amgen Oncology (Anti-cancer Drugs) Product
    Table 129. Amgen Recent Development
    Table 130. Johnson & Johnson Company Information
    Table 131. Johnson & Johnson Introduction and Business Overview
    Table 132. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 133. Johnson & Johnson Oncology (Anti-cancer Drugs) Product
    Table 134. Johnson & Johnson Recent Development
    Table 135. GlaxoSmithKline Company Information
    Table 136. GlaxoSmithKline Introduction and Business Overview
    Table 137. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 138. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product
    Table 139. GlaxoSmithKline Recent Development
    Table 140. Eli lilly & Co Company Information
    Table 141. Eli lilly & Co Introduction and Business Overview
    Table 142. Eli lilly & Co Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 143. Eli lilly & Co Oncology (Anti-cancer Drugs) Product
    Table 144. Eli lilly & Co Recent Development
    Table 145. Pfizer Company Information
    Table 146. Pfizer Introduction and Business Overview
    Table 147. Pfizer Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 148. Pfizer Oncology (Anti-cancer Drugs) Product
    Table 149. Pfizer Recent Development
    Table 150. Merck & Co. Company Information
    Table 151. Merck & Co. Introduction and Business Overview
    Table 152. Merck & Co. Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 153. Merck & Co. Oncology (Anti-cancer Drugs) Product
    Table 154. Merck & Co. Recent Development
    Table 155. Sanofi Company Information
    Table 156. Sanofi Introduction and Business Overview
    Table 157. Sanofi Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
    Table 158. Sanofi Oncology (Anti-cancer Drugs) Product
    Table 159. Sanofi Recent Development
    Table 160. Key Raw Materials Lists
    Table 161. Raw Materials Key Suppliers Lists
    Table 162. Oncology (Anti-cancer Drugs) Market Trends
    Table 163. Oncology (Anti-cancer Drugs) Market Drivers
    Table 164. Oncology (Anti-cancer Drugs) Market Challenges
    Table 165. Oncology (Anti-cancer Drugs) Market Restraints
    Table 166. Oncology (Anti-cancer Drugs) Distributors List
    Table 167. Oncology (Anti-cancer Drugs) Downstream Customers
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Oncology (Anti-cancer Drugs) Product Picture
    Figure 2. Global Oncology (Anti-cancer Drugs) Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Oncology (Anti-cancer Drugs) Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Oncology (Anti-cancer Drugs) Sales Status and Outlook (2018-2029) & (K MT)
    Figure 5. Product Picture of Blood Cancer
    Figure 6. Global Blood Cancer Sales YoY Growth (2018-2029) & (K MT)
    Figure 7. Product Picture of Breast Cancer
    Figure 8. Global Breast Cancer Sales YoY Growth (2018-2029) & (K MT)
    Figure 9. Product Picture of Gastrointestinal Cancer
    Figure 10. Global Gastrointestinal Cancer Sales YoY Growth (2018-2029) & (K MT)
    Figure 11. Product Picture of Prostate Cancer
    Figure 12. Global Prostate Cancer Sales YoY Growth (2018-2029) & (K MT)
    Figure 13. Product Picture of Others
    Figure 14. Global Others Sales YoY Growth (2018-2029) & (K MT)
    Figure 15. Global Oncology (Anti-cancer Drugs) Sales by Type (2018-2029) & (US$ Million)
    Figure 16. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type in 2022 & 2029
    Figure 17. North America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type in 2022
    Figure 18. North America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type in 2022
    Figure 19. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type in 2022
    Figure 20. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type in 2022
    Figure 21. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type in 2022
    Figure 22. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type in 2022
    Figure 23. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type in 2022
    Figure 24. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type in 2022
    Figure 25. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type in 2022
    Figure 26. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type in 2022
    Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology (Anti-cancer Drugs) Sales in 2022
    Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology (Anti-cancer Drugs) Revenue in 2022
    Figure 29. Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 30. Product Picture of Chemotherapy
    Figure 31. Global Chemotherapy Sales YoY Growth (2018-2029) & (K MT)
    Figure 32. Product Picture of Targeted Therapy
    Figure 33. Global Targeted Therapy Sales YoY Growth (2018-2029) & (K MT)
    Figure 34. Product Picture of Immunotherapy (Biologic Therapy)
    Figure 35. Global Immunotherapy (Biologic Therapy) Sales YoY Growth (2018-2029) & (K MT)
    Figure 36. Product Picture of Hormonal Therapy
    Figure 37. Global Hormonal Therapy Sales YoY Growth (2018-2029) & (K MT)
    Figure 38. Product Picture of Others
    Figure 39. Global Others Sales YoY Growth (2018-2029) & (K MT)
    Figure 40. Global Oncology (Anti-cancer Drugs) Sales by Application (2018-2029) & (US$ Million)
    Figure 41. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application in 2022 & 2029
    Figure 42. North America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application in 2022
    Figure 43. North America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application in 2022
    Figure 44. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application in 2022
    Figure 45. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application in 2022
    Figure 46. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application in 2022
    Figure 47. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application in 2022
    Figure 48. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application in 2022
    Figure 49. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application in 2022
    Figure 50. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application in 2022
    Figure 51. Key Raw Materials Price
    Figure 52. Oncology (Anti-cancer Drugs) Manufacturing Cost Structure
    Figure 53. Oncology (Anti-cancer Drugs) Industrial Chain Analysis
    Figure 54. Channels of Distribution
    Figure 55. Distributors Profiles
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS